Kanabo’s Medical-Cannabis Product Coming to UK – MarketWatch
By Anthony O. Goriainoff
Kanabo Group PLC said Wednesday that its medicinal-cannabis cartridges will be available shortly for U.K. patients, and that its first order is expected to arrive in the U.K. next week.
The U.K.-based medicinal cannabis company said the product will be distributed under the name Noidecs as agreed with the Lyphe Group and its wholly-owned subsidiary Astral Health Ltd. The cartridges have been produced as part of Kanabo’s partnership with Warsaw-based PharmaCann Polska.
The company said its prefilled, sealed cartridges–which can only be used with the company’s VapePod device–will be sold as prescribed, unlicensed medicine to patients of Lyphe Group’s U.K. clinics and dispensaries, including The Medical Cannabis Clinic.
Shares at 0730 GMT were up 0.25 pence, or 1.5%, at 16.75 pence
Write to Anthony O. Goriainoff at firstname.lastname@example.org